stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - Spyre Therapeutics, Inc. | StockGist | StockGist
Companies
SYRE
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
SYRE
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
Spyre Therapeutics, Inc.
Filed Feb 17, 2026
Accepted Feb 16, 2026, 7:00 PM ET
SYRE
CIK 0001636282
View on SEC.gov
Company Profile
0001214659-26-002024
Beneficial Ownership Report
Passive Investment
Shares Owned
77,592,130
Reporting Person
Spyre Therapeutics, Inc.
Person Type
OO
CUSIP: 00773J202
Amendment History
3 filings
SCHEDULE 13G
Original
Jul 29, 2025
0000932471-25-001050
SCHEDULE 13G/A
Amendment 1
Viewing
Feb 17, 2026
0001214659-26-002024
SCHEDULE 13G/A
Amendment 2
Latest
Mar 27, 2026
0000102909-26-002337